Sabra Health Care REIT Inc. Stock Downgraded (SBRA)
- The company, on the basis of change in net income from the same quarter one year ago, has significantly underperformed when compared to that of the S&P 500 and the Real Estate Investment Trusts (REITs) industry. The net income has significantly decreased by 44.7% when compared to the same quarter one year ago, falling from $7.16 million to $3.96 million.
- Net operating cash flow has decreased to $8.35 million or 18.10% when compared to the same quarter last year. Despite a decrease in cash flow SABRA HEALTH CARE REIT INC is still fairing well by exceeding its industry average cash flow growth rate of -42.58%.
- The return on equity has improved slightly when compared to the same quarter one year prior. This can be construed as a modest strength in the organization. When compared to other companies in the Real Estate Investment Trusts (REITs) industry and the overall market, SABRA HEALTH CARE REIT INC's return on equity is below that of both the industry average and the S&P 500.
- 47.30% is the gross profit margin for SABRA HEALTH CARE REIT INC which we consider to be strong. Regardless of SBRA's high profit margin, it has managed to decrease from the same period last year. Despite the mixed results of the gross profit margin, SBRA's net profit margin of 13.99% is significantly lower than the industry average.
- SABRA HEALTH CARE REIT INC's earnings per share declined by 42.1% in the most recent quarter compared to the same quarter a year ago. This company has reported somewhat volatile earnings recently. But, we feel it is poised for EPS growth in the coming year. During the past fiscal year, SABRA HEALTH CARE REIT INC increased its bottom line by earning $0.53 versus $0.39 in the prior year. This year, the market expects an improvement in earnings ($1.32 versus $0.53).
-- Written by a member of TheStreet Ratings Staff
It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts